Zerodha > Trade @ ₹20 (Free Delivery)Know More
Free Account Opening + AMC Free Demat

Aptus Pharma IPO vs Topsun Energy IPO

Comparison between Aptus Pharma IPO and Topsun Energy IPO.

IPO Details

Aptus Pharma IPO is a SME Bookbuilding IPO proposed to list at BSE SME while Topsun Energy IPO is a SME Bookbuilding proposed to list at BSE SME.

 Aptus Pharma IPOTopsun Energy IPO
LogoAptus Pharma IPO LogoTopsun Energy IPO Logo
Issue CategorySMESME
Issue TypeIPOIPO
Process TypeBookbuildingBookbuilding
Listing AtBSE SMEBSE SME
Lead ManagersInteractive Financial Services Ltd.Interactive Financial Services Ltd.
RegistrarBigshare Services Pvt.Ltd.Bigshare Services Pvt.Ltd.
Market MakerAftertrade Broking Pvt.Ltd.
DRHPDRHP DRHP
RHP
Anchor Investor
IPO Allotment URL

Issue Size and Price

The total issue size of Aptus Pharma IPO is up to ₹0.00 Cr whereas the issue size of the Topsun Energy IPO is up to ₹0.00 Cr. The final issue price of Aptus Pharma IPO is and of Topsun Energy IPO is .

 Aptus Pharma IPOTopsun Energy IPO
Face Value₹10 per share₹10 per share
Issue Price (Lower)
Issue Price (Upper)
Issue Price (Final)
Discount (Retail)
Discount (Employee)
Market Lot Size
Fresh Issue Size20,00,000 shares72,00,000 shares
Fresh Issue Size (Amount)up to ₹0.00 Crup to ₹0.00 Cr
OFS Issue Size0 shares0 shares
OFS Issue Size (Amount)up to ₹0.00 Crup to ₹0.00 Cr
Issue Size Total20,00,000 shares72,00,000 shares
Issue Size Total (Amount)up to ₹0.00 Crup to ₹0.00 Cr

IPO Timetable

Aptus Pharma IPO opens on , while Topsun Energy IPO opens on . The closing date of Aptus Pharma IPO and Topsun Energy IPO is , and , respectively.

 Aptus Pharma IPOTopsun Energy IPO
Anchor Bid Date
Issue Open
Issue Close
Basis Of Allotment (Tentative)
Initiation of Refunds (Tentative)
Credit of Share (Tentative)
Listing date (Tentative)
Anchor Lockin End date 1
Anchor Lockin End date 2

Financials & KPIs

Aptus Pharma IPO P/E ratio is , as compared to Topsun Energy IPO P/E ratio of .

 Aptus Pharma IPOTopsun Energy IPO
Financials

Aptus Pharma Limited Financial Information (Restated)

Aptus Pharma Limited's revenue increased by 38% and profit after tax (PAT) rose by 288% between the financial year ending with March 31, 2025 and March 31, 2024.

Period Ended31 Mar 202531 Mar 202431 Mar 2023
Assets21.9210.036.22
Total Income24.6417.8813.90
Profit After Tax3.100.800.19
EBITDA4.761.490.57
Net Worth6.971.770.97
Reserves and Surplus1.971.470.67
Total Borrowing10.365.312.21
Amount in ₹ Crore

Topsun Energy Limited Financial Information (Restated Standalone)

Period Ended31 Dec 202431 Mar 202431 Mar 202331 Mar 2022
Assets134.36104.5361.1169.40
Total Income141.02105.4866.7093.48
Profit After Tax8.313.11-2.240.55
EBITDA16.898.970.855.01
Net Worth38.3230.0126.9029.13
Reserves and Surplus27.0718.7615.6517.88
Total Borrowing48.4045.7827.8925.52
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue)10099.36
Promoter Shareholding (Post-Issue)
P/E Ratio
Market Cap
ROE24.33%
ROCE19.74%
Debt/Equity1.26
EPS
RoNW10.37%

Shares Offered

In the Aptus Pharma IPO Retail Individual Investors (RII) are offered while in Topsun Energy IPO retail investors are offered . Qualified Institutional Buyers (QIB) are offered in Aptus Pharma IPO and in Topsun Energy IPO.

 Aptus Pharma IPOTopsun Energy IPO
Anchor Investor Reserveration
Market Maker Reserveration
QIB
NII
RII
Employee
Others
Total

Bids Received (Subscription)

Aptus Pharma IPO subscribed in total, whereas Topsun Energy IPO subscribed .

 Aptus Pharma IPOTopsun Energy IPO
QIB (times)
NII (times)
Big NII (times)
Small NII (times)
RII (times)
Employee (times)
Other (times)
Total (times)